Dosimetric Challenges for Residential Radon Epidemiology

Abstract

Radon concentration alone may not be an adequate surrogate to measure for lung cancer risk in all residential radon epidemiologic lung cancer studies. The dose delivered to the lungs per unit radon exposure can vary significantly with exposure conditions. These dose-effectiveness variations can be comparable to spatial and temporal factor variations in many situations. New technologies that use surface-deposited and implanted radon progeny activities make more accurate dose estimates available for future epidemiologic studies.

This work was made possible, in part, by grant R01 CA85942 from the National Cancer Institute, National Institutes of Health.

Salary support for Drs. Steck and Field was provided in part by grant numbers R01 ES05653 and P30 ES05605 from the National Institute of Environmental Health Sciences, NIH and grant number R01 CA85942 from the National Cancer Institute, NIH.

Notes

This work was made possible, in part, by grant R01 CA85942 from the National Cancer Institute, National Institutes of Health.

Salary support for Drs. Steck and Field was provided in part by grant numbers R01 ES05653 and P30 ES05605 from the National Institute of Environmental Health Sciences, NIH and grant number R01 CA85942 from the National Cancer Institute, NIH.